QQQ   444.36 (-0.11%)
AAPL   171.00 (-1.33%)
MSFT   420.15 (-0.30%)
META   486.36 (-1.52%)
GOOGL   150.47 (-0.27%)
AMZN   180.21 (+0.21%)
TSLA   176.37 (-1.92%)
NVDA   906.00 (+0.39%)
NIO   4.61 (-1.28%)
AMD   181.35 (+0.98%)
BABA   72.42 (+1.16%)
T   17.58 (+0.17%)
F   13.29 (+1.76%)
MU   118.04 (-0.92%)
CGC   9.95 (+4.19%)
GE   175.47 (-2.58%)
DIS   122.88 (+1.57%)
AMC   3.69 (-14.98%)
PFE   27.90 (+0.43%)
PYPL   67.12 (+0.83%)
XOM   115.74 (+0.67%)
QQQ   444.36 (-0.11%)
AAPL   171.00 (-1.33%)
MSFT   420.15 (-0.30%)
META   486.36 (-1.52%)
GOOGL   150.47 (-0.27%)
AMZN   180.21 (+0.21%)
TSLA   176.37 (-1.92%)
NVDA   906.00 (+0.39%)
NIO   4.61 (-1.28%)
AMD   181.35 (+0.98%)
BABA   72.42 (+1.16%)
T   17.58 (+0.17%)
F   13.29 (+1.76%)
MU   118.04 (-0.92%)
CGC   9.95 (+4.19%)
GE   175.47 (-2.58%)
DIS   122.88 (+1.57%)
AMC   3.69 (-14.98%)
PFE   27.90 (+0.43%)
PYPL   67.12 (+0.83%)
XOM   115.74 (+0.67%)
QQQ   444.36 (-0.11%)
AAPL   171.00 (-1.33%)
MSFT   420.15 (-0.30%)
META   486.36 (-1.52%)
GOOGL   150.47 (-0.27%)
AMZN   180.21 (+0.21%)
TSLA   176.37 (-1.92%)
NVDA   906.00 (+0.39%)
NIO   4.61 (-1.28%)
AMD   181.35 (+0.98%)
BABA   72.42 (+1.16%)
T   17.58 (+0.17%)
F   13.29 (+1.76%)
MU   118.04 (-0.92%)
CGC   9.95 (+4.19%)
GE   175.47 (-2.58%)
DIS   122.88 (+1.57%)
AMC   3.69 (-14.98%)
PFE   27.90 (+0.43%)
PYPL   67.12 (+0.83%)
XOM   115.74 (+0.67%)
QQQ   444.36 (-0.11%)
AAPL   171.00 (-1.33%)
MSFT   420.15 (-0.30%)
META   486.36 (-1.52%)
GOOGL   150.47 (-0.27%)
AMZN   180.21 (+0.21%)
TSLA   176.37 (-1.92%)
NVDA   906.00 (+0.39%)
NIO   4.61 (-1.28%)
AMD   181.35 (+0.98%)
BABA   72.42 (+1.16%)
T   17.58 (+0.17%)
F   13.29 (+1.76%)
MU   118.04 (-0.92%)
CGC   9.95 (+4.19%)
GE   175.47 (-2.58%)
DIS   122.88 (+1.57%)
AMC   3.69 (-14.98%)
PFE   27.90 (+0.43%)
PYPL   67.12 (+0.83%)
XOM   115.74 (+0.67%)
NASDAQ:DFFN

Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.17
$5.19
50-Day Range
$4.38
$6.60
52-Week Range
$2.76
$7.40
Volume
351,000 shs
Average Volume
10,937 shs
Market Capitalization
$8.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DFFN stock logo

About Diffusion Pharmaceuticals Stock (NASDAQ:DFFN)

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

DFFN Stock News Headlines

Diffusion Pharmaceuticals Inc.
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals Inc. (DFFN)
DFFN: Phase 2 GBM Trial to Initiate 2H22…
See More Headlines
Receive DFFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diffusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DFFN
Employees
13
Year Founded
N/A

Profitability

Net Income
$-15,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$6.97 per share

Miscellaneous

Free Float
2,003,000
Market Cap
$8.98 million
Optionable
Not Optionable
Beta
1.78
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Robert J. Cobuzzi Jr. (Age 58)
    Ph.D., Pres & CEO
    Comp: $691.79k
  • Mr. William Robert Elder J.D. (Age 40)
    Gen. Counsel & Corp. Sec.
    Comp: $413.92k
  • Dr. David Randolph Jones M.D. (Age 60)
    Sr. Medical Advisor
  • Mr. Harry Cook
    VP of Clinical Operations
  • Mr. Douglas Gravatt
    Sr. Consultant for Manufacturing
  • Mr. Brian D. Bollwage
    Sr. Consultant - Regulatory Affairs

DFFN Stock Analysis - Frequently Asked Questions

How were Diffusion Pharmaceuticals' earnings last quarter?

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($9.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.00) by $6.00.

When did Diffusion Pharmaceuticals' stock split?

Shares of Diffusion Pharmaceuticals reverse split before market open on Thursday, August 17th 2023. The 1-1.5 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 67 shares after the split.

What other stocks do shareholders of Diffusion Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diffusion Pharmaceuticals investors own include Matinas BioPharma (MTNB), Bionano Genomics (BNGO), ADMA Biologics (ADMA), Novan (NOVN), Zosano Pharma (ZSAN), Gran Tierra Energy (GTE), Cogent Biosciences (UMRX), Aeterna Zentaris (AEZS), Sorrento Therapeutics (SRNE) and Enerplus (ERF).

This page (NASDAQ:DFFN) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners